Vera Therapeutics (VERA)
Vera Therapeutics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
13.6M
Short interest
settlement 2026-10-15
7.2
Days to cover
-0.6 days vs prior
50.7%
Short share of volume
2026-11-02
7
Fails to deliver
settlement 2026-10-09
Wed 4 Nov
Next earnings
estimated date
-$1.3M
Insider flow, 90 days
0 buys, 2 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in VERA is 13,587,185 shares, down 3,447,855 shares over the last month. Over the last 48 readings it ranged from 5,958,240 shares (30 April 2025) to 19,873,297 shares (31 August 2026). At the reported average volume of 1.9M shares a day that is 7.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/vera" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 13,587,185 | -21.2% | 1,895,769 | 7.17 |
| 2026-09-30 | 17,240,397 | +1.2% | 2,212,016 | 7.79 |
| 2026-09-15 | 17,035,040 | -14.3% | 2,755,223 | 6.18 |
| 2026-08-31 | 19,873,297 | +18.2% | 1,838,051 | 10.81 |
| 2026-08-14 | 16,814,429 | +10.0% | 2,418,287 | 6.95 |
| 2026-07-31 | 15,281,960 | +1.3% | 1,621,443 | 9.42 |
| 2026-07-15 | 15,081,995 | +11.6% | 3,021,677 | 4.99 |
| 2026-06-30 | 13,520,658 | +14.2% | 2,303,446 | 5.87 |
| 2026-06-15 | 11,839,194 | +9.3% | 1,138,434 | 10.40 |
| 2026-05-29 | 10,833,205 | +7.5% | 969,229 | 11.18 |
| 2026-05-15 | 10,077,450 | +7.4% | 1,010,135 | 9.98 |
| 2026-04-30 | 9,386,187 | -4.9% | 987,670 | 9.50 |
| 2026-04-15 | 9,872,666 | +1.1% | 1,424,319 | 6.93 |
| 2026-03-31 | 9,764,156 | +18.3% | 1,243,195 | 7.85 |
| 2026-03-13 | 8,250,811 | +8.0% | 1,333,573 | 6.19 |
| 2026-02-27 | 7,638,754 | -4.9% | 937,318 | 8.15 |
| 2026-02-13 | 8,033,354 | -0.8% | 970,199 | 8.28 |
| 2026-01-30 | 8,094,375 | +0.6% | 1,034,010 | 7.83 |
| 2026-01-15 | 8,045,451 | -4.9% | 1,143,839 | 7.03 |
| 2025-12-31 | 8,459,021 | -7.5% | 1,186,140 | 7.13 |
| 2025-12-15 | 9,145,275 | -15.5% | 2,259,719 | 4.05 |
| 2025-11-28 | 10,818,660 | +8.6% | 1,388,747 | 7.79 |
| 2025-11-14 | 9,962,227 | +7.6% | 2,021,334 | 4.93 |
| 2025-10-31 | 9,259,969 | -5.1% | 1,120,531 | 8.26 |
| 2025-10-15 | 9,755,730 | -1.8% | 1,064,935 | 9.16 |
| 2025-09-30 | 9,938,712 | +6.2% | 1,729,064 | 5.75 |
| 2025-09-15 | 9,358,966 | +10.3% | 1,834,070 | 5.10 |
| 2025-08-29 | 8,481,686 | +9.2% | 1,939,382 | 4.37 |
| 2025-08-15 | 7,770,438 | +2.6% | 1,566,343 | 4.96 |
| 2025-07-31 | 7,572,615 | -8.1% | 922,962 | 8.20 |
| 2025-07-15 | 8,238,798 | -6.5% | 924,827 | 8.91 |
| 2025-06-30 | 8,816,548 | -7.8% | 1,681,143 | 5.24 |
| 2025-06-13 | 9,560,166 | +6.8% | 4,437,580 | 2.15 |
| 2025-05-30 | 8,947,513 | +26.6% | 1,134,205 | 7.89 |
| 2025-05-15 | 7,069,204 | +18.6% | 1,519,741 | 4.65 |
| 2025-04-30 | 5,958,240 | -2.0% | 765,995 | 7.78 |
| 2025-04-15 | 6,078,809 | -7.1% | 1,140,070 | 5.33 |
| 2025-03-31 | 6,541,492 | -9.8% | 971,090 | 6.74 |
| 2025-03-14 | 7,250,076 | -7.0% | 624,543 | 11.61 |
| 2025-02-28 | 7,797,445 | -6.7% | 1,013,627 | 7.69 |
| 2025-02-14 | 8,357,773 | +3.1% | 1,095,264 | 7.63 |
| 2025-01-31 | 8,102,354 | +11.1% | 780,698 | 10.38 |
| 2025-01-15 | 7,290,035 | +1.9% | 686,479 | 10.62 |
| 2024-12-31 | 7,153,678 | +5.2% | 704,622 | 10.15 |
| 2024-12-13 | 6,798,203 | +4.3% | 413,304 | 16.45 |
| 2024-11-29 | 6,519,748 | -0.4% | 527,456 | 12.36 |
| 2024-11-15 | 6,546,438 | +2.5% | 934,709 | 7.00 |
| 2024-10-31 | 6,389,681 | +3.2% | 1,139,421 | 5.61 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of VERA volume is 50.7%, down 4.0 points over the last five sessions. Over the last 30 readings it ranged from 28.0% (6 October 2026) to 74.4% (30 October 2026). The latest reading is in line with the 30-session average of 50.6%, on 771K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 391K | 771K | 50.7% | 400 |
| 2026-10-30 | 326K | 439K | 74.4% | 0 |
| 2026-10-29 | 282K | 569K | 49.6% | 1,201 |
| 2026-10-28 | 312K | 709K | 44.0% | 1 |
| 2026-10-27 | 167K | 420K | 39.9% | 4,186 |
| 2026-10-26 | 291K | 532K | 54.7% | 120 |
| 2026-10-23 | 447K | 875K | 51.0% | 17,351 |
| 2026-10-22 | 432K | 1.4M | 31.5% | 0 |
| 2026-10-21 | 326K | 795K | 41.0% | 49 |
| 2026-10-20 | 214K | 503K | 42.6% | 0 |
| 2026-10-19 | 318K | 510K | 62.3% | 22 |
| 2026-10-16 | 218K | 350K | 62.4% | 399 |
| 2026-10-15 | 249K | 554K | 44.9% | 200 |
| 2026-10-14 | 352K | 687K | 51.3% | 0 |
| 2026-10-13 | 415K | 1.1M | 36.4% | 9 |
| 2026-10-12 | 269K | 675K | 39.9% | 0 |
| 2026-10-09 | 178K | 310K | 57.5% | 500 |
| 2026-10-08 | 248K | 470K | 52.8% | 349 |
| 2026-10-07 | 464K | 1.3M | 36.5% | 0 |
| 2026-10-06 | 337K | 1.2M | 28.0% | 100 |
| 2026-10-05 | 318K | 942K | 33.7% | 0 |
| 2026-10-02 | 397K | 728K | 54.5% | 0 |
| 2026-10-01 | 276K | 430K | 64.3% | 0 |
| 2026-09-30 | 334K | 519K | 64.3% | 0 |
| 2026-09-29 | 323K | 540K | 59.9% | 6 |
| 2026-09-28 | 281K | 473K | 59.5% | 0 |
| 2026-09-25 | 278K | 472K | 58.9% | 0 |
| 2026-09-24 | 493K | 707K | 69.8% | 12,627 |
| 2026-09-23 | 500K | 958K | 52.2% | 10,776 |
| 2026-09-22 | 452K | 904K | 50.0% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in VERA is 7 shares, down 43 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (18 August 2026) to 23,233 shares (17 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 7 | $29.73 | $208 |
| 2026-10-06 | 50 | $29.83 | $1K |
| 2026-10-02 | 4,630 | $30.99 | $143K |
| 2026-09-25 | 66 | $33.34 | $2K |
| 2026-09-22 | 604 | $34.25 | $21K |
| 2026-09-21 | 484 | $34.00 | $16K |
| 2026-09-16 | 15 | $33.67 | $505 |
| 2026-09-14 | 14 | $35.05 | $491 |
| 2026-09-09 | 967 | $35.28 | $34K |
| 2026-08-31 | 586 | $34.19 | $20K |
| 2026-08-18 | 3 | $31.63 | $95 |
| 2026-08-14 | 977 | $28.89 | $28K |
| 2026-08-04 | 137 | $32.23 | $4K |
| 2026-07-30 | 4,442 | $32.51 | $144K |
| 2026-07-17 | 23,233 | $39.12 | $909K |
| 2026-07-16 | 5,608 | $42.50 | $238K |
| 2026-07-15 | 1,546 | $43.13 | $67K |
| 2026-07-14 | 2,376 | $41.50 | $99K |
| 2026-07-13 | 2,057 | $42.00 | $86K |
| 2026-07-10 | 101 | $42.45 | $4K |
| 2026-07-09 | 6 | $42.43 | $255 |
| 2026-07-08 | 183 | $42.96 | $8K |
| 2026-07-02 | 202 | $42.66 | $9K |
| 2026-07-01 | 821 | $42.91 | $35K |
| 2026-06-30 | 12,271 | $43.15 | $529K |
| 2026-06-29 | 1,150 | $42.46 | $49K |
| 2026-06-26 | 1,168 | $40.50 | $47K |
| 2026-06-25 | 1,900 | $39.51 | $75K |
| 2026-06-18 | 72 | $35.01 | $3K |
| 2026-06-15 | 2,786 | $34.26 | $95K |
Insider trades
SEC Form 4, newest first. JSONInsiders at VERA reported 2 open-market sells worth $1.3M in the last 90 days and no open-market buys. Latest filing: Fordyce Marshall (PRESIDENT AND CEO) on 2026-09-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19K | $37.00 | $685K | 235K |
| 2026-09-15 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 19K | $2.90 | $54K | 254K |
| 2026-09-11 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion | 5K | $3.94 | $20K | 81K |
| 2026-09-02 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 19K | $35.12 | $650K | 235K |
| 2026-09-02 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 19K | $2.90 | $54K | 254K |
| 2026-08-03 | Boman Nancy Lee | Chief Regulatory Officer | Grant | 45K | $0.00 | $0 | 45K |
| 2026-07-07 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $43.59 | $96K | 152K |
| 2026-07-07 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 11K | $42.86 | $450K | 154K |
| 2026-07-07 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 33K | $42.07 | $1.4M | 165K |
| 2026-07-07 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 1K | $40.78 | $41K | 197K |
| 2026-06-23 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 88 | $38.43 | $3K | 198K |
| 2026-06-23 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 18K | $37.93 | $698K | 198K |
| 2026-05-12 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 4K | $37.09 | $159K | 217K |
| 2026-05-12 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14K | $36.64 | $521K | 221K |
| 2026-04-14 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 900 | $45.51 | $41K | 235K |
| 2026-04-14 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 8K | $44.58 | $353K | 236K |
| 2026-04-14 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 14K | $43.66 | $617K | 244K |
| 2026-03-23 | Wright-Mitchell Jane | Chief Legal Officer | Grant | 42K | $0.00 | $0 | 42K |
| 2026-03-13 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion | 10K | $3.94 | $39K | 76K |
| 2026-02-23 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 3K | $41.98 | $131K | 65K |
| 2026-02-23 | Turner William D. | Chief Regulatory Officer | Sell | 2K | $41.98 | $92K | 45K |
| 2026-02-23 | Skelton Laurence Matthew | Chief Commercial Officer | Sell | 2K | $41.98 | $66K | 64K |
| 2026-02-23 | JOHNSON DAVID LEE | Chief Operating Officer | Sell | 3K | $41.98 | $108K | 46K |
| 2026-02-23 | Grant Sean | CHIEF FINANCIAL OFFICER | Sell | 5K | $41.98 | $208K | 114K |
| 2026-02-23 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 17K | $41.98 | $711K | 257K |
| 2026-02-23 | Brenner Robert | Chief Medical Officer | Sell | 2K | $41.98 | $90K | 51K |
| 2026-02-04 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Grant | 10K | $0.00 | $0 | 68K |
| 2026-02-04 | Turner William D. | Chief Regulatory Officer | Grant | 25K | $0.00 | $0 | 48K |
| 2026-02-04 | Skelton Laurence Matthew | Chief Commercial Officer | Grant | 20K | $0.00 | $0 | 66K |
| 2026-02-04 | JOHNSON DAVID LEE | Chief Operating Officer | Grant | 20K | $0.00 | $0 | 48K |
| 2026-02-04 | Grant Sean | CHIEF FINANCIAL OFFICER | Grant | 25K | $0.00 | $0 | 119K |
| 2026-02-04 | Fordyce Marshall | PRESIDENT AND CEO | Grant | 69K | $0.00 | $0 | 274K |
| 2026-02-04 | Brenner Robert | Chief Medical Officer | Grant | 25K | $0.00 | $0 | 53K |
| 2025-12-15 | Turner William D. | Chief Regulatory Officer | Sell | 10K | $50.08 | $501K | 23K |
| 2025-12-15 | Turner William D. | Chief Regulatory Officer | Exercise or conversion | 10K | $15.53 | $155K | 33K |
| 2025-12-11 | ENRIGHT PATRICK G | Director | Buy | 6K | $42.50 | $250K | 6K |
| 2025-12-08 | Turner William D. | Chief Regulatory Officer | Sell | 10K | $45.31 | $453K | 23K |
| 2025-12-08 | Turner William D. | Chief Regulatory Officer | Exercise or conversion | 10K | $15.53 | $155K | 33K |
| 2025-12-03 | Turner William D. | Chief Regulatory Officer | Sell | 10K | $40.00 | $400K | 23K |
| 2025-12-03 | Turner William D. | Chief Regulatory Officer | Exercise or conversion | 10K | $15.53 | $155K | 33K |
| 2025-11-21 | Carter Jason S | Chief Legal Officer | Sell | 4K | $27.82 | $107K | 49K |
| 2025-11-13 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Exercise or conversion | 10K | $3.94 | $39K | 58K |
| 2025-11-11 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Sell | 15K | $29.06 | $436K | 48K |
| 2025-06-24 | ENRIGHT PATRICK G | Director | Buy | 27K | $22.35 | $605K | 3.6M |
| 2025-06-24 | ENRIGHT PATRICK G | Director | Buy | 14K | $22.35 | $303K | 1.8M |
| 2025-06-23 | ENRIGHT PATRICK G | Director | Buy | 140K | $20.87 | $2.9M | 3.6M |
| 2025-06-23 | ENRIGHT PATRICK G | Director | Buy | 70K | $20.87 | $1.5M | 1.8M |
| 2025-02-26 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 1K | $28.32 | $31K | 205K |
| 2025-02-26 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 8K | $27.55 | $220K | 206K |
| 2025-02-21 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 11K | $27.89 | $296K | 214K |
| 2025-02-18 | JOHNSON DAVID LEE | Chief Operating Officer | Grant | 27K | $0.00 | $0 | 27K |
| 2025-02-18 | Fordyce Marshall | PRESIDENT AND CEO | Grant | 81K | $0.00 | $0 | 224K |
| 2025-02-18 | Grant Sean | CHIEF FINANCIAL OFFICER | Grant | 27K | $0.00 | $0 | 93K |
| 2025-02-18 | Brenner Robert | Chief Medical Officer | Grant | 27K | $0.00 | $0 | 27K |
| 2025-02-18 | Turner William D. | Chief Development Officer | Grant | 23K | $0.00 | $0 | 23K |
| 2025-02-18 | Young Joseph R | SVP, FINANCE, CHIEF ACCT OFFCR | Grant | 11K | $0.00 | $0 | 62K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 6K | $2.90 | $16K | 149K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 145K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 6K | $42.03 | $237K | 144K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $42.00 | $79K | 144K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 10K | $41.53 | $414K | 144K |
| 2025-01-08 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 10K | $2.90 | $29K | 154K |
| 2024-12-19 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 58K | $2.90 | $167K | 144K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 5K | $2.90 | $15K | 91K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $42.35 | $93K | 86K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $6K | 88K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 4K | $41.33 | $156K | 86K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 5K | $2.90 | $13K | 91K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $43.81 | $82K | 86K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 5K | $44.03 | $204K | 86K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 5K | $43.52 | $219K | 86K |
| 2024-12-18 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 4K | $2.90 | $11K | 90K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 15K | $2.90 | $43K | 101K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 100 | $47.65 | $5K | 86K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 100 | $2.90 | $290 | 86K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $46.94 | $83K | 86K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 700 | $47.55 | $33K | 86K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 700 | $2.90 | $2K | 87K |
| 2024-12-11 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 15K | $46.91 | $700K | 86K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $49.00 | $92K | 86K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 8K | $2.90 | $22K | 94K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 1K | $2.90 | $4K | 87K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 8K | $48.18 | $369K | 86K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 1K | $48.80 | $67K | 86K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $49.00 | $92K | 86K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 7K | $2.90 | $19K | 93K |
| 2024-11-25 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 7K | $47.05 | $310K | 86K |
| 2024-11-18 | Carter Jason S | Chief Legal Officer | Grant | 53K | $0.00 | $0 | 53K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $49.50 | $93K | 86K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 2K | $49.52 | $93K | 86K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 2K | $2.90 | $5K | 88K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 3K | $50.28 | $166K | 86K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 3K | $2.90 | $10K | 89K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Sell | 12K | $49.54 | $605K | 86K |
| 2024-11-13 | Fordyce Marshall | PRESIDENT AND CEO | Exercise or conversion | 12K | $2.90 | $35K | 98K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON14 Form 144 notices on file for VERA worth $9.5M at the prices reported; 1 in the last 90 days worth $2.2M. Latest: MARSHALL FORDYCE filed on 2026-09-02 to sell 64,750 shares ($2.2M) from 2026-09-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-02 | MARSHALL FORDYCEDirector, Officer | 65K | $2.2M | 0.090% | 2026-09-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-23 | MARSHALL FORDYCEDirector, Officer | 74K | $2.8M | 0.103% | 2026-06-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-12 | MARSHALL FORDYCEDirector, Officer | 19K | $677K | 0.026% | 2026-05-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-14 | MARSHALL FORDYCEDirector, Officer | 23K | $1.0M | 0.032% | 2026-04-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | WILLIAM DONALD TURNEROfficer | 3K | $109K | 0.004% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | LAURENCE SKELTONOfficer | 2K | $76K | 0.003% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | DAVID L JOHNSONOfficer | 3K | $122K | 0.005% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | SEAN GRANTOfficer | 6K | $240K | 0.009% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | MARSHALL FORDYCEOfficer | 17K | $698K | 0.026% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | ROBERT BRENNEROfficer | 3K | $105K | 0.004% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-15 | WILLIAM TURNEROfficer | 10K | $498K | 0.016% | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-08 | WILLIAM TURNEROfficer | 10K | $449K | 0.016% | 2025-12-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-03 | WILLIAM TURNEROfficer | 10K | $373K | 0.016% | 2025-12-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-24 | Carter Jason SOfficer | 4K | $108K | 0.006% | 2025-11-21 | Morgan Stanley Smith Barney LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON6 holders report 5% or more of VERA in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 7.4% of the class (5,340,522 shares), filed 2026-07-30 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Kynam Capital Management GP, LLCother entity | 0 | 4.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Kynam Capital Management, LPinvestment adviser | 0 | 4.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Yue Tangindividual | 0 | 4.0% | 2026-06-30 |
| 2026-08-07 | 13G | STATE STREET CORPORATIONparent holding company | 4.1M | 5.8% | 2026-06-30 |
| 2026-07-30 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 5.3M | 7.4% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 3 | T. Rowe Price Associates, Inc.investment adviser | 4.6M | 6.4% | 2026-03-31 |
| 2026-04-01 | 13G | Steven A. Cohenindividual | 1.2M | 1.7% | 2026-03-25 |
| 2026-04-01 | 13G | Point72 Capital Advisors, Inc.corporation | 1.2M | 1.7% | 2026-03-25 |
| 2026-04-01 | 13G | Point72 Asset Management, L.P.partnership | 1.2M | 1.7% | 2026-03-25 |
| 2026-03-27 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-03-11 | 13G | Deep Track Biotechnology Master Fund, Ltd.corporation | 3.9M | 5.5% | 2026-03-04 |
| 2026-03-11 | 13G | Deep Track Capital, LPinvestment adviser, other entity | 3.9M | 5.5% | 2026-03-04 |
| 2026-03-11 | 13G | David Kroinparent holding company, individual | 3.9M | 5.5% | 2026-03-04 |
| 2026-03-05 | 13D/Ano. 5 | Dr. Maha Katabi ("Katabi")individual | 2.8M | 4.0% | 2025-12-10 |
| 2026-03-05 | 13D/Ano. 5 | Sofinnova Venture Partners X, L.P. ("SVP X")partnership | 2.8M | 3.9% | 2025-12-10 |
| 2026-03-05 | 13D/Ano. 5 | Sofinnova Management X, L.P. ("SM X LP")partnership | 2.8M | 3.9% | 2025-12-10 |
| 2026-03-05 | 13D/Ano. 5 | Sofinnova Management X-A, L.L.C. ("SM X LLC")other entity | 2.8M | 3.9% | 2025-12-10 |
| 2026-03-05 | 13D/Ano. 5 | Dr. James I. Healy ("Healy")individual | 2.8M | 3.9% | 2025-12-10 |
| 2026-02-05 | 13G/Ano. 6 | FMR LLCparent holding company | 2.9M | 4.1% | 2025-12-31 |
| 2026-02-05 | 13G/Ano. 6 | Abigail P. Johnsonindividual | 2.9M | 4.1% | 2025-12-31 |
13F holders
Tracked managers holding VERA at their latest 13F. JSON6 of the 30 tracked managers held VERA at their latest 13F, $34.1M in total at quarter-end prices. Renaissance Technologies is the largest at $12.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 280K | $12.0M | 0.02% | -178K |
| Millennium Management | 2026-06-30 | 279K | $12.0M | 0.00% | -15K |
| Two Sigma Investments | 2026-06-30 | 104K | $4.5M | 0.00% | -106K |
| D. E. Shaw & Co. | 2026-06-30 | 75K | $3.2M | 0.00% | +69K |
| Point72 Asset Management | 2026-06-30 | 41K | $1.7M | 0.00% | -1.2M |
| AQR Capital Management | 2026-06-30 | 16K | $694K | 0.00% | +165 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn FY 2025 it generated -$241.1M of operating cash flow. As of 2026-06-30, cash was $48.9M against $75.2M of debt.
- Cash
- $48.9M
- Debt
- $75.2M
- Equity
- $407.8M
- Total assets
- $533.0M
- Shares outstanding
- 72,063,335
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | n/a | -$109.5M | n/a | -1.52 |
| Q1 FY 2026 | 2026-03-31 | n/a | -$121.0M | n/a | -1.69 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$91.1M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$80.3M | n/a | -1.26 |
| Q2 FY 2025 | 2025-06-30 | n/a | -$76.5M | n/a | -1.20 |
| Q1 FY 2025 | 2025-03-31 | n/a | -$51.7M | n/a | -0.81 |
| Q4 FY 2024derived | 2024-12-31 | n/a | -$43.4M | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | n/a | -$46.6M | n/a | -0.85 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | n/a | -$299.6M | -$241.1M | $630K | $0 | n/a |
| FY 2024 | 2024-12-31 | n/a | -$152.1M | -$134.7M | $972K | $13K | n/a |
| FY 2023 | 2023-12-31 | n/a | -$96.0M | -$92.2M | $63K | $0 | n/a |
| FY 2022 | 2022-12-31 | n/a | -$89.1M | -$67.6M | $62K | n/a | n/a |
| FY 2021 | 2021-12-31 | n/a | -$32.6M | -$23.7M | $0 | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-29 from the cover page.
What this page is
Vera Therapeutics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Vera Therapeutics (VERA), SEC CIK 1831828, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-10.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1831828Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of VERA is sold short?
13,587,185 shares were held short at the 2026-10-15 settlement, 7.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is VERA's daily short volume?
On 2026-11-02, 390,939 of the 770,600 VERA shares reported to FINRA were sold short, 50.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does VERA have fails to deliver?
The SEC's latest file shows 7 VERA shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are VERA insiders buying or selling?
Insiders at VERA reported 2 open-market sells worth $1.3M in the last 90 days and no open-market buys. Latest filing: Fordyce Marshall (PRESIDENT AND CEO) on 2026-09-15.
Have VERA insiders filed to sell?
14 Form 144 notices on file for VERA worth $9.5M at the prices reported; 1 in the last 90 days worth $2.2M. Latest: MARSHALL FORDYCE filed on 2026-09-02 to sell 64,750 shares ($2.2M) from 2026-09-02.
Who owns 5% or more of VERA?
6 holders report 5% or more of VERA in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 7.4% of the class (5,340,522 shares), filed 2026-07-30 for an event on 2026-06-30.
What did VERA report last quarter?
In FY 2025 it generated -$241.1M of operating cash flow. As of 2026-06-30, cash was $48.9M against $75.2M of debt.
Which tracked 13F managers own VERA?
6 of the 30 tracked 13F managers held VERA shares at their latest filing, $34.1M in all. The largest: Renaissance Technologies (280K shares, $12.0M), Izzy Englander's Millennium Management (279K shares, $12.0M), Two Sigma Investments (104K shares, $4.5M), D. E. Shaw & Co. (75K shares, $3.2M), Steve Cohen's Point72 Asset Management (41K shares, $1.7M), Cliff Asness's AQR Capital Management (16K shares, $694K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.